MARKET

BJDX

BJDX

Bluejay Diagnostics Inc
NASDAQ
1.780
0.000
0.00%
Opening 12:32 05/13 EDT
OPEN
1.830
PREV CLOSE
1.780
HIGH
1.830
LOW
1.730
VOLUME
19.94K
TURNOVER
--
52 WEEK HIGH
316.92
52 WEEK LOW
1.460
MARKET CAP
2.66M
P/E (TTM)
-0.0156
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BJDX last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at BJDX last week (0428-0502)?
Weekly Report · 05/05 11:53
Bluejay Diagnostics files to sell 1.09M shares of common stock for holders
TipRanks · 04/29 21:35
Weekly Report: what happened at BJDX last week (0421-0425)?
Weekly Report · 04/28 12:05
Weekly Report: what happened at BJDX last week (0414-0418)?
Weekly Report · 04/21 12:04
Bluejay Diagnostics Announces Acceptance Of Abstract Related To Symphony IL-6 Test For Presentation At SAEM Annual Meeting
Benzinga · 04/15 11:20
Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting
TipRanks · 04/15 11:11
Weekly Report: what happened at BJDX last week (0407-0411)?
Weekly Report · 04/14 11:51
More
About BJDX
Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a rapid, near-patient testing system for triage and monitoring of disease progression. Its product candidate, an IL-6 Test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform is a combination of its intellectual property (IP) and exclusively licensed and patented IP that consists of a mobile device and single-use test cartridges. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices market, including sepsis, cardio-metabolic diseases, cancer and other diseases that require rapid tests. Symphony targets critical care markets where physicians must quickly determine patient acuity to identify optimal treatment regimens.

Webull offers Bluejay Diagnostics Inc stock information, including NASDAQ: BJDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BJDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BJDX stock methods without spending real money on the virtual paper trading platform.